Stockreport

Belite Bio to Participate in Four Upcoming Investor Conferences

Belite Bio, Inc - American Depositary Shares  (BLTE) 
PDF SAN DIEGO, April 23, 2026 (GLOBE NEWSWIRE) -- Belite Bio, Inc (NASDAQ: BLTE) (“Belite Bio” or the “Company”), a clinical-stage drug development company focused on adva [Read more]